[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350449-105":3,"detail-sidebar-cat-0-en-105":73,"doc-detail-350449-en":122},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":66,"head_meta":68,"extra_data":70,"updated_unix":72},105,"en","mirna-mediated-signaling-networks-in-non-small-cell-lung-cancer-linking-tumor-progression-to-sarcopenia","miRNA-Mediated Signaling Networks in Non-Small Cell Lung Cancer - Linking Tumor Progression to Sarcopenia","","Non-small cell lung cancer (NSCLC) drives major cancer mortality despite advances in surgery, chemotherapy, targeted therapy, and immunotherapy. The tumor microenvironment (TME) supports tumor growth, immune escape, and systemic metabolic disruption. This work integrates differential microRNA analyses to define dysregulated signaling networks. hsa-miR-486-5p modulates PI3K/AKT/mTOR, NF-κB, and JAK-STAT3 signaling, enhancing progression and inflammatory cytokine secretion.",{"@graph":14,"@context":65},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mirna-mediated-signaling-networks-in-non-small-cell-lung-cancer-linking-tumor-progression-to-sarcopenia/350449/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mirna-mediated-signaling-networks-in-non-small-cell-lung-cancer-linking-tumor-progression-to-sarcopenia/350449.png","ImageObject",300,407,{"name":42,"@type":43},"Dipper","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59],{"name":60,"@type":61,"acceptedAnswer":62},"What therapeutic implication does the study emphasize?","Question",{"text":63,"@type":64},"The findings suggest RNA-based therapeutic strategies, including miRNA-targeted interventions, to overcome resistance, improve survival, and address metabolic complications associated with NSCLC.","Answer","https://schema.org",{"og:url":32,"og:type":67,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":69,"canonical":32},"index,follow",{"doc_id":71,"site_id":7},350449,1790545504,{"code":4,"msg":74,"data":75},"success",[76,80,84,88,93,98,103,106,111,114,118],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":77,"show_sort_weight":78,"slug":79},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":81,"show_sort_weight":82,"slug":83},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Exam",70,"exam",{"id":89,"doc_module":4,"doc_module_name":25,"category_name":90,"show_sort_weight":91,"slug":92},5,"Comic",60,"comic",{"id":94,"doc_module":4,"doc_module_name":25,"category_name":95,"show_sort_weight":96,"slug":97},6,"Technology",50,"technology",{"id":99,"doc_module":4,"doc_module_name":25,"category_name":100,"show_sort_weight":101,"slug":102},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":104,"slug":105},30,"research-report",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},9,"Religion & Spirituality",20,"religion-spirituality",{"id":109,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":109,"slug":113},"World Cup","world-cup",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":115,"slug":117},10,"Lifestyle","lifestyle",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":89,"slug":121},19,"General","general",{"code":4,"msg":74,"data":123},{"doc_id":71,"user_id":124,"nickname":42,"user_avatar":125,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":131,"language":132,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":12,"update_tm":136,"read_time":137,"preview_page_count":33,"preview_urls":138},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \nmiRNA-Mediated Signaling Networks in Non-Small Cell Lung Cancer: Linking Tumor Progression to Sarcopenia  \nSwati Goswami 1,2, Pooja Gulhane 1 and Shailza Singh 1,2, *  \nAcademic Editor: Santosh Anand  \nReceived: 17 February 2026  \nRevised: 31 March 2026  \nAccepted: 4 April 2026  \nPublished: 23 May 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Systems Medicine Laboratory, BRIC—National Centre for Cell Science, National Centre for Cell Science Complex, SPPU Campus, Ganeshkhind, Pune 411007, India  \n2 Regional Centre for Biotechnology, Faridabad 121001, India  \n* Correspondence: singhs@nccs.res.in; Tel.: +91-20-25708296/95; Fax: +91-20-25692259  \nAbstract  \nNon-small cell lung cancer (NSCLC) remains a major cause of cancer-related mortality, with poor survival outcomes despite advances in surgery, chemotherapy, targeted therapy, and immunotherapy. The tumor microenvironment (TME) plays a central role in sustaining tumor growth, immune evasion, and systemic metabolic dysfunction. In this study, we performed an integrative analysis of differentially expressed microRNAs (miRNAs) to uncover their contributions to dysregulated signaling networks in NSCLC. hsa-miR- 486-5p was identified as a prominent differentially expressed candidate miRNA. Using mathematical modeling and regression-based reduction, we identified Forkhead Box O1 (FOXO1) and Unc-51 like Autophagy Activating Kinase 2 (ULK2) as critical regulatory nodes that integrate oncogenic signaling with cellular homeostasis. Aberrant expression of hsa-miR-486-5p was found to modulate pathways including PI3K/AKT/mTOR, NF-κB, and JAK-STAT3, thereby promoting tumor progression and secretion of inflammatory cytokines. These cytokines, viz., IL-6, TNF-α, and IL-1β, activate muscle-specific protein degradation pathways through E3 ubiquitin ligases TRIM63 and FBXO32, linking NSCLC progression to cancer-associated sarcopenia. Quasipotential landscape analysis further revealed dynamic phenotypic transitions between stable and unstable states, highlighting the adaptability of tumor–host interactions. Collectively, our findings demonstrate that miRNA-mediated regulatory networks not only drive NSCLC progression and inflammation but also contribute to systemic muscle wasting. These insights emphasize the need for novel therapeutic strategies, including RNA-based interventions, to overcome resistance, improve survival, and address the metabolic complications associated with NSCLC.  \nKeywords: cancer; miRNA; NSCLC; FOXO1; TME; sarcopenia  \n1. Introduction  \nAmong the non-communicable diseases, cancer remains one of the leading causes of mortality all over the globe. The estimated GLOBOCAN 2022 data depicted approximately 20 million new cases of cancer and nearly 10 million deaths due to cancer worldwide. With nearly 2.48 million new cases and 1.8 million deaths reported in 2022, lung cancer has become the most commonly diagnosed cancer around the world, making it a serious public health concern. For both sexes combined, lung cancer alone accounts for nearly 18% of the total deaths caused by cancer every year. Incidence of lung cancer is more prevalent among males, exhibiting ≈1.57 million cases as compared with females, accounting for ≈0.91 million cases [1] . The latest Indian data from the National Cancer Registry  \nProgramme (NCRP), reported for the years 2012–16, classified lung cancer as the leading type of cancer significantly prevalent in metropolitan areas [2,3] . Lung cancer can be classified as small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), accounting for nearly 15% and 85% of total lung cancer, respectively. NSCLC accounts for major cases of lung cancer and is broadly classified as lung adenocarcinoma, squamous cell carcinoma, and large cell carcinoma [4–6] . Based upon an Indian Counc","cbCaijNOjtXz9lks","https://ap.wps.com/l/cbCaijNOjtXz9lks","pdf",35061266,23,"English","# Abstract\n## Introduction","[{\"question\":\"What therapeutic implication does the study emphasize?\",\"answer\":\"The findings suggest RNA-based therapeutic strategies, including miRNA-targeted interventions, to overcome resistance, improve survival, and address metabolic complications associated with NSCLC.\"}]","miRNA-Mediated Signaling Networks in Non-Small Cell Lung Cancer - Linking Tumor Progression to Sarcopenia | PDF",1790089092,58,[139,143,147,151],{"page_no":22,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc49109bea79838ff8871ce1fa517199.webp",983,1390,{"page_no":26,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8954cb8a69bb168c9e918405b5b6c46.webp",982,1388,{"page_no":30,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/330d75b1cf6ee4617be7970b2ec11cf6.webp",981,1387,{"page_no":33,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37c050f53fb1e6e5d4690a0ed3f70221.webp",980,1385]